Shanghai HeartCare Medical Technology Corporation Limited

Shanghai HeartCare Medical Technology Corporation Limitedverified

6609.HK

Price:

$45.46

Market Cap:

$1.56B

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and i...[Read more]

Industry

Medical - Devices

IPO Date

2021-08-20

Stock Exchange

HKSE

Ticker

6609.HK

The PE Ratio as of December 2025 (TTM) for Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) is 37.57

According to Shanghai HeartCare Medical Technology Corporation Limited’s latest financial reports and current stock price. The company's current PE Ratio is 37.57. This represents a change of -349.04% compared to the average of -15.09 of the last 4 quarters.

Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) Historical PE Ratio (quarterly & annually)

How has 6609.HK PE Ratio performed in the past?

The mean historical PE Ratio of Shanghai HeartCare Medical Technology Corporation Limited over the last ten years is -28.01. The current 37.57 PE Ratio has changed -13512.05% with respect to the historical average. Over the past ten years (40 quarters), 6609.HK's PE Ratio was at its highest in in the June 2025 quarter at 13.30. The PE Ratio was at its lowest in in the June 2020 quarter at -163.42.

Quarterly (TTM)
Annual

Average

-28.01

Median

-17.18

Minimum

-59.44

Maximum

-6.20

Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shanghai HeartCare Medical Technology Corporation Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 423.52%

Maximum Annual PE Ratio = -6.20

Minimum Annual Increase = -66.81%

Minimum Annual PE Ratio = -59.44

Quarterly (TTM)
Annual
YearPE RatioChange
2024-57.16423.52%
2023-10.9276.16%
2022-6.20-57.65%
2021-14.63-25.82%
2020-19.73-66.81%

Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) Average PE Ratio

How has 6609.HK PE Ratio performed in the past?

The current PE Ratio of Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-24.76

5-year avg

-21.73

10-year avg

-28.01

Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) PE Ratio vs. Peers

How is 6609.HK’s PE Ratio compared to its peers?

Shanghai HeartCare Medical Technology Corporation Limited’s PE Ratio is greater than Sisram Medical Ltd (12.29), greater than Concord Healthcare Grp Co Ltd (-2.83), greater than Shanghai Bio-heart Biological Technology Co., Ltd. (-15.58), greater than Sipai Health Technology Co., Ltd. (-4.06), greater than Town Health International Medical Group Limited (-12.06), greater than Shanghai Pioneer Holding Ltd (21.48), greater than PW Medtech Group Limited (12.25), greater than Gaush Meditech Ltd (11.60), greater than SinoMab BioScience Limited (-10.41), greater than Chaoju Eye Care Holdings Limited (9.95),

Build a custom stock screener for Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai HeartCare Medical Technology Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai HeartCare Medical Technology Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Shanghai HeartCare Medical Technology Corporation Limited's PE Ratio?

How is the PE Ratio calculated for Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)?

What is the highest PE Ratio for Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)?

What is the 3-year average PE Ratio for Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)?

What is the 5-year average PE Ratio for Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)?

How does the current PE Ratio for Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) compare to its historical average?